Close Menu

US Patent No. 9,080,215

MicroRNAs differentially expressed in cervical cancer and uses thereof
Jul 23, 2015

Asuragen has been awarded US Patent No. 9,080,215, "MicroRNAs differentially expressed in cervical cancer and uses thereof."

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.

Sponsored by

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.